Reliq Health Technologies Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Chris Shields

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	less than a year
CEO ownership	n/a
Management average tenure	3yrs
Board average tenure	5.2yrs

Recent management updates

Recent updates

CEO

Chris Shields

less than a year

Tenure

Mr. Chris Shields serves as Chief Executive Officer of Reliq Health Technologies Inc. since 2024 and served as its Interim Chief Executive Officer since December 2023 and serves as its Director since Decem...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Chris Shields	CEO & Director	less than a year	no data	no data
Kevin Cornish	Chief Financial Officer	less than a year	no data	no data
Dave McKay	Chief Technology & Innovation Officer	3yrs	no data	no data
Lucas Smithen	Chief Product Officer	no data	no data	no data
Joyce Johnson	Chief Medical Officer & Medical Advisory Board Member	4yrs	no data	no data
Chris Ryan	Chief Strategy Officer	3.3yrs	no data	no data

3.0yrs

Average Tenure

Experienced Management: MHN2's management team is considered experienced (3 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Chris Shields	CEO & Director	less than a year	no data	no data
Joyce Johnson	Chief Medical Officer & Medical Advisory Board Member	no data	no data	no data
Eugene Beukman	Director	8.8yrs	CA$78.00k	0.10% CA$ 33.0k
Brian Storseth	Independent Director	7.8yrs	CA$120.00k	0.064% CA$ 20.5k
Scott Howell	Medical Advisory Board Member	5.2yrs	no data	no data
Bruce Kinosian	Medical Advisory Board Member	5.2yrs	no data	no data
Alexander Nuttall	Independent Non-Executive Director	less than a year	no data	no data
Camellus Ezeugwu	Medical Advisory Board Member	no data	no data	no data
Leo Godreault	Medical Advisory Board Member	no data	no data	no data

5.2yrs

Average Tenure

50.5yo

Average Age

Experienced Board: MHN2's board of directors are considered experienced (5.2 years average tenure).

Reliq Health Technologies Management

Management criteria checks 2/4

Key information

Recent management updates

Reliq Health Technologies, Inc. Announces Chief Financial Officer Changes

Reliq Health Technologies, Inc. Announces Chief Financial Officer Changes

Reliq Health Technologies, Inc. Announces the Appointment of Directors

Reliq Health Technologies Inc Announces Executive Changes

Reliq Health Technologies Inc., Annual General Meeting, Dec 21, 2023

Less than half of directors are independent

Recent updates

Reliq Health Technologies, Inc. Announces Chief Financial Officer Changes

Reliq Health Technologies, Inc. Announces Chief Financial Officer Changes

New minor risk - Financial data availability

Reliq Health Technologies, Inc. Announces the Appointment of Directors

Reliq Health Technologies Inc Announces Executive Changes

Reliq Health Technologies Inc., Annual General Meeting, Dec 21, 2023

Reliq Health Technologies Inc. announced that it has received CAD 6 million in funding

New minor risk - Financial position

Reliq Health Technologies Inc. announced that it expects to receive CAD 4 million in funding

Third quarter 2023 earnings released: EPS: CA$0.038 (vs CA$0.004 loss in 3Q 2022)

Second quarter 2023 earnings released: EPS: CA$0 (vs CA$0.012 loss in 2Q 2022)

First quarter 2023 earnings released: CA$0.001 loss per share (vs CA$0.024 loss in 1Q 2022)

Reliq Health Technologies Inc. to Report Q2, 2023 Results on Mar 01, 2023

Less than half of directors are independent

Full year 2022 earnings released: CA$0.046 loss per share (vs CA$0.075 loss in FY 2021)

Reliq Health Technologies Inc. to Report Q1, 2023 Results on Nov 29, 2022

Reliq Health Technologies Inc., Annual General Meeting, Dec 21, 2022

Reliq Health Technologies, Inc. Announces Court Approval of Settlement of Proposed Class Action

Third quarter 2022 earnings released: CA$0.004 loss per share (vs CA$0.017 loss in 3Q 2021)

Reliq Health Technologies Inc. to Report Fiscal Year 2022 Results on Oct 28, 2022

Less than half of directors are independent

Second quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Reliq Health Technologies Inc. to Report Q3, 2022 Results on May 30, 2022

Reliq Health Technologies Inc. Announces Settlement of Class Action

First quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Full year 2021 earnings released: CA$0.075 loss per share (vs CA$0.082 loss in FY 2020)

Reliq Health Technologies Inc. Provides Update on Significant Expansion of Texas Medicaid Coverage, More Than Doubling the Eligible Patient Population for Reliq in TX

Reliq Health Technologies Inc. Provides Sales Guidance for the Fourth Quarter and Full Year Ending June 30, 2021

Third quarter 2021 earnings released: CA$0.017 loss per share (vs CA$0.021 loss in 3Q 2020)

Reliq Health Technologies, Inc. Announces Implementation of FHIR Standard for Interoperability to Address New CMS Regulations

Reliq Health Technologies, Inc. Announces New Contract with a Physician Practice in Florida to Provide iUGO Care to over 25 Skilled Nursing Facilities

Insider recently sold €86k worth of stock

Second quarter 2021 earnings released: CA$0.029 loss per share (vs CA$0.03 loss in 2Q 2020)

New 90-day high: €0.58

Reliq Health Technologies Inc. Announces New Contract with US Nephrology Clinic to Provide iUGO Care to Chronic Kidney Disease Patients

Reliq Health Technologies, Inc. Announces New Contract with Care Management Network in California

New 90-day high: €0.36

Reliq Health Technologies, Inc. Announces First Contract to Deploy its iUGO Home Solution

Reliq Health Technologies Inc. Launches Its New Multilingual Interactive Voice Recognition Product, iUGO Care IVR

Reliq Health Technologies, Inc. Launches New Annual Wellness Visit Product and Announces New US Contract

New 90-day high: €0.20

New 90-day high: €0.20

Reliq Health Technologies, Inc. Announces 15 New Clients

First quarter 2021 earnings released: CA$0.018 loss per share

Reliq Health Technologies Inc. to Report Q2, 2021 Results on Mar 02, 2021

Full year earnings released - €0.082 loss per share

Reliq Health Technologies Inc. to Report Q1, 2021 Results on Nov 30, 2020

Reliq Health Technologies, Inc. Announces Strategic Alliance with iDocsWeb to Offer its iUGO Care platform to iDocsWeb's 200 Skilled Nursing Facility Clients across the United States

Reliq Health Technologies Inc. Signs A Contract with the University of Notre Dame Australia to Deploy iUGO Well to its Students and Staff

CEO

Tenure

Leadership Team

Average Tenure

Board Members

Average Tenure

Average Age